Actovegin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Actovegin, a deproteinized haemodialysate of calf blood, is suggested to have ergogenic properties, but this potential effect has… (More)
Is this relevant?
2014
2014
This study aimed to investigate whether Actovegin, which is a deproteinized ultrafiltrate derived from calf blood, demonstrates… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2012
2012
BACKGROUND Diabetic neuropathy is one of the most severe complications of diabetes, affecting approximately one-third of diabetic… (More)
Is this relevant?
2011
2011
The recently described therapeutic benefits of the hemodialysate actovegin on neuropathic symptoms in diabetic patients with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
PURPOSE A multi-center prospective randomized trial was conducted to evaluate the efficacy and safety of Actovegin in the… (More)
Is this relevant?
2009
2009
OBJECTIVE To evaluate the efficacy and safety of actovegin in patients with diabetic polyneuropathy. RESEARCH DESIGN AND METHODS… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To study the healing effect of recombinant human epidermal growth factor (hEGF) on diabetic foot ulcers. RESEARCH… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
1998
1998
In a rat model of 5-min clinical death caused by massive blood loss actovegin prevented the development of metabolic disorders… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1995
1995
A double-blind randomized clinical trial was performed comparing the therapeutic effects of Actovegin versus placebo in elderly… (More)
Is this relevant?
1990